Dose Response Relationship Between Fat Ingestion and Metabolism
NCT ID: NCT05906342
Last Updated: 2025-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2023-07-01
2024-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Does Class of Dietary Fat Affect Insulin Resistance?
NCT01541592
The Influence of Overfeeding Different Macronutrients on Whole-body Insulin Sensitivity
NCT03863431
Metabolic Adaptations to High-fat Diet
NCT06537401
Effects of Dietary Fibre on Glucose Metabolism and Satiety
NCT02093481
Glucose-stimulated Gut Lipid Release
NCT03464240
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
20% fat meal
This meal will contain 15 kcal/kg of body weight and consist of 20% fat, 65% carbohydrates, and 15% protein.
20% fat meal
Provided to participants once throughout duration of study, contains 20% fat
40% fat meal
This meal will contain 15 kcal/kg of body weight and consist of 40% fat, 45% carbohydrates, and 15% protein.
40% fat meal
Provided to participants once throughout duration of study, contains 40% fat
60% fat meal
This meal will contain 15 kcal/kg of body weight and consist of 60% fat, 25% carbohydrates, and 15% protein.
60% fat meal
Provided to participants once throughout duration of study, contains 60% fat
80% fat meal
This meal will contain 15 kcal/kg of body weight and consist of 80% fat, 5% carbohydrates, and 15% protein.
80% fat meal
Provided to participants once throughout duration of study, contains 80% fat
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
20% fat meal
Provided to participants once throughout duration of study, contains 20% fat
40% fat meal
Provided to participants once throughout duration of study, contains 40% fat
60% fat meal
Provided to participants once throughout duration of study, contains 60% fat
80% fat meal
Provided to participants once throughout duration of study, contains 80% fat
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Weight stable for the past 6 months (± 2kg)
* VO2max values within a below average to above average range (38-50 mL/kg and 35-47 mL/kg for 18-25 year old males and females respectively. 35-48 mL/kg and 34-45 mL/kg for 26-35 year old males and females respectively)
* Fasting blood glucose \<6.0 mM
* Resting blood pressure \<140/90 mmHg
* Taking second generation oral contraceptives (females only)
Exclusion Criteria
* Diabetes, cancer, or other metabolic disorders
* Cardiac or gastrointestinal problems
* Infectious disease
* Barium swallow or nuclear medicine scan in the previous 3 weeks
* Follow a strict vegan diet
* Pregnant or breastfeeding (females only)
* Diagnosis of polycystic ovary syndrome (females only)
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McMaster University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kirsten Bell
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
McMaster University, Ivor Wynne Centre
Hamilton, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16153
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.